Novel Management of Periodontal Conditions

Presented by: Dr. Howard Tenenbaum

RCDSO Expiry Date: February 28, 2019

To qualify as a Core Category 1 course, the course certificate must be issued no later than this date.

RCDSO CE Points: 3, Category 1

Click to close
  • Dr. Howard Tenenbaum

    Professor of Periodontology,
    Faculty of Dentistry University of Toronto
    Professor Laboratory Medicine and Pathobiology,
    Faculty of Medicine, University of Toronto
    Head Division of Research, Department of Dentistry, Mount Sinai Hospital

    Dr. Tenenbaum received his D.D.S. from the University of Toronto in 1978 and then completed his specialty in Periodontology as well as a Ph.D. in bone cell biology by 1982. This was followed by a 2-year post-doctoral MRC fellowship in Bethesda at the National Institutes of Health. In addition to his degrees, Dr. Tenenbaum has a Fellowship from the Royal College of Dentists of Canada, as well as the International College of Dentists and the Academy of Dentistry International.

    Dr. Tenenbaum is a Professor of Periodontology, and was Head of that Discipline for 8 years (1997-2005), at the Faculty of Dentistry, University of Toronto. He was also Associate Dean for Biological and Diagnostic Sciences for 6 years having just stepped down September 2007 to pursue his research more actively. He is a cross-appointed Professor in the Department of Laboratory Medicine and Pathophysiology, Faculty of Medicine, University of Toronto and is the Head of the Division of Research in the Department of Dentistry at Mount Sinai Hospital. Dr. Tenenbaum also serves as an FDA panel member for Dental Devices and Drugs (USA) and is Vice-Chair of the Federal Dental Care Advisory Committee (Canada).

    Dr. Tenenbaum has had research funding from the Medical Research Council of Canada, CIHR (Canadian Institutes for Health Research) and other agencies for the past 25 years and has pursued ongoing research in the fields of bone cell biology (including a series of bone cell studies aboard the US Space Shuttle carried out by Senator John Glenn), periodontics, and orofacial pain. He has published over 140 articles, book chapters and abstracts in major scientific and clinical journals and has lectured nationally and internationally on several topics including orofacial pain, cellular biology of bone, and management of refractory periodontal diseases.

Current Status
Not Enrolled
Get Started

PLEASE NOTE: THIS COURSE CAN NO LONGER BE TAKEN FOR CE POINTS. This course is available now for review by registered users to reprint their Certificates if needed. It has expired and can no longer be taken to achieve CE points or certificates.

Most patients who have periodontitis respond to routine management, which can include scaling and root planning, periodontal flap surgery (regenerative or respective) and, when treatment fails, the placement of endosseous implants. In general 80% of patients will respond to routine therapy, but the problem remains: what do we do about those who do not respond?

This course is an updated version of the original course Novel Management of the Periodontal Patient: Surgery and Beyond available in the last CDE Cycle. If the original course was claimed by an RCDSO member in Category 1 in the previous cycle, the updated version can only be claimed by that RCDSO member in Category 2 for the current cycle.